Top story
AstraZeneca made a $10 billion offer for Rhythm Pharmaceuticals, WSJ reports
The reported bid would be a sizable bolt-on for AstraZeneca's rare disease and obesity pipeline and follows a wave of large pharma M&A.
ReutersAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources sayUsnewsAstraZeneca Made $10 Billion Offer for Obesity Drugmaker Rhythm, Sources SayMarketscreenerAstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reportsYahooAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reportsInvestingliveAstraZeneca makes $10 billion offer for obesity drugmaker Rhythm, WSJ reportsKeloAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reportsSrnnewsAstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reportsTradingviewRhythm Pharmaceuticals jumps on report AstraZeneca made $10B bidTwaslnewsAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources sayInvestingAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say By ReutersFinimizeAstraZeneca Weighs A $10 Billion Bid For Rhythm PharmaYahooRYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid ReportMSNAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports